Categories AlphaGraphs, Analysis, Retail
Earnings preview: Weak holiday sales might weigh on Big Lots’ Q4 results
Big Lots (BIG) will be reporting its fourth-quarter results Friday before the opening bell. It is widely expected that the community retailer will report earnings of $2.3 per share on revenues of $1.6 billion, which represents a decline from the year-ago period.
While comparable store sales remain positive, the decline in store count could impact profitability negatively. Though there is skepticism over its fourth-quarter performance, considering the weak holiday season, the company expects sequential improvement in the bottom-line performance.
The fact that earnings remained subdued throughout last year is a cause for concern as it reflects the underlying pressure on margins. For the quarter under reference, the company had forecast that comparable sales will be flat to up 2%.
While comparable store sales remain positive, the decline in store count could impact profitability negatively
In the third quarter, Big Lots slipped to a net loss mainly due to higher expenses, despite a marked increase in sales. Discouraged by the unimpressive results, the management lowered its guidance for the rest of the year, triggering a stock selloff. The bottom-line missed both the company’s own estimate and that of analysts.
Costco (COST), the leading warehouse retailer, is slated to report its second-quarter results Wednesday after the closing bell. Dollar General (DG) will be unveiling earnings of the most recent quarter on March 14 before the market opens.
Also see: Big Lots Q3 2018 Earnings Conference Call Transcript
The consensus analysts’ rating on Big Lots stock is hold and the average price target is $35.5. The recommendation is based on the moderate stock price and the positive outlook on the company for the current year.
Big Lots shares are yet to recover from the sharp fall they suffered after the dismal third-quarter results. The stock lost about 34% since last year and is currently trading near the five-year low. Of late, the stock has been gathering momentum and gained 9% since the beginning of the year.
Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on